BlogInsights

Patented Gold Standard Handheld Digital Spirometer Alveofit

1 min readUpdated 11 September 2025

Patent has been granted for an invention entitled A WIRELESS HANDHELD DIGITAL SPIROMETER

The long-awaited announcement has finally been made: the Government of India and the IP Office have officially recognized our invention and granted us a patent for our low-flow technology. This is a huge step forward for us, and we are extremely grateful for the support of the authorities in making this happen. we are committed to working hard to make sure that it lives up to its potential. We would like to thank everyone who has been involved in this process, and we look forward to continued success in the future.

A patent has been granted to the patentee for an invention entitled a wireless handheld digital spirometer. Our Alveofit digital Spirometer is a handheld device that can measure a person's lung function. It is a non-invasive way to measure a person's lung function and can be used by anyone. This device can be used to help diagnose and treat lung conditions and to monitor a person's lung function over time.

We would like to express our sincere gratitude to Forge Innovation and incubation Center, NASSCOM Foundation, BIRAC, and AstraZeneca for their generous support of our work. This device is a breakthrough in the field of respiratory diagnostics, and we are confident that it will have a profound impact on the lives of many people. We are deeply grateful to have had the opportunity
to work with such an outstanding team of individuals and organizations, and we look forward to continuing to build on this success in the future.

See alveofit in your clinic.

A 30-minute demo of oscillometry, spirometry and alveoConnect, on your own patients' workflow.

Book a demo
  1. Acquisition time of 15–30 seconds of tidal breathing per recording, from the alveoflow FOT System specification. Applies to alveoflow Pro and alveoflow Neo.
  2. FHIR R4 and HL7 v2 export from the alveoflow FOT System specification. ABDM integration supported.
  3. CDSCO Class B under MDR 2017. ISO 13485 and MDSAP as stated on alveo.fit. alveoflow: US 510(k) submission pending; not cleared for sale in the United States. alveoair is US FDA 510(k) cleared (K222525, August 2023).
  4. Screens show example data and do not represent a real patient. Interpretation is the responsibility of the treating clinician.